Cargando…

The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

Detalles Bibliográficos
Autor principal: Christopoulos, Panagiotis F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589397/
https://www.ncbi.nlm.nih.gov/pubmed/34473900
http://dx.doi.org/10.1002/iid3.521
_version_ 1784598704864362496
author Christopoulos, Panagiotis F.
author_facet Christopoulos, Panagiotis F.
author_sort Christopoulos, Panagiotis F.
collection PubMed
description
format Online
Article
Text
id pubmed-8589397
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85893972021-11-19 The future of tumor vaccines in the post‐COVID‐19 era—Current challenges Christopoulos, Panagiotis F. Immun Inflamm Dis Short Reports John Wiley and Sons Inc. 2021-09-02 /pmc/articles/PMC8589397/ /pubmed/34473900 http://dx.doi.org/10.1002/iid3.521 Text en © 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Reports
Christopoulos, Panagiotis F.
The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
title The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
title_full The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
title_fullStr The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
title_full_unstemmed The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
title_short The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
title_sort future of tumor vaccines in the post‐covid‐19 era—current challenges
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589397/
https://www.ncbi.nlm.nih.gov/pubmed/34473900
http://dx.doi.org/10.1002/iid3.521
work_keys_str_mv AT christopoulospanagiotisf thefutureoftumorvaccinesinthepostcovid19eracurrentchallenges
AT christopoulospanagiotisf futureoftumorvaccinesinthepostcovid19eracurrentchallenges